The Trillion-Dollar Conspiracy (21 page)

The original Burroughs Wellcome drug firm was wholly owned by Wellcome Trust, whose director was the British lord Oliver Franks, a man described as “one of the founders of the post-war world.” Franks was ambassador to the United States from 1948 to 1952 and was also a director of the Rockefeller Foundation and its principal representative in England. He was a director of the Kurt von Schroeder Nazi Bank, which at one time handled Hitler’s personal bank account. Franks also was a director of the Rhodes Trust, which was used in the late 1800s by the African diamond magnate Cecil Rhodes to create his Round Table Groups, a forerunner of the Council on Foreign Relations. As a Rhodes director, Franks was in charge of approving Rhodes scholarships such as the one awarded Bill Clinton in 1968.

According to former intelligence officer Dr. John Coleman, members of Rhodes’s Round Tables, armed with immense wealth gained from control of gold, diamonds, and drugs, fanned out over the world to take control of fiscal and monetary policies and political leadership in all countries where they operated. This conspiratorial network was confirmed by President Clinton’s academic mentor, the Georgetown University historian Carroll Quigley, who wrote, “There does exist, and has existed for a generation, an international Anglophile network which operates, to some extent, in the way the radical Right believes the Communists act. I know of the operations of this network because I have studied it for 20 years and was permitted for two years, in the early 1960s, to examine its papers and secret records. I have no aversion to it or to most of its aims and have, for much of my life, been close to it and to many of its instruments…. [I]n general my chief difference of opinion is that it wishes to remain unknown, and I believe its role in history is significant enough to be known.”

While Franks is known as director of the trust that owned a large drug company, most people do not know the extent of the Rockefellers’ influence over modern medicine and drugs.

According to Eustace Mullins, the drug industry is controlled by a Rockefeller “Medical Monopoly,” largely through directors on pharmaceutical boards representing Rockefeller entities. “The American College of Surgeons maintained a monopolistic control of hospitals through the powerful Hospital Survey Committee, with members Winthrop Aldrich and David McAlpine Pyle representing the Rockefeller control.”

Winthrop Aldrich, whose sister was married to John D. Rockefeller Jr., served as president and board chairman of Chase National Bank from 1930 to 1953. He also served on the Committee on the Cost of Medical Care (CCMC), which was started by Dr. Alexander Lambert, the personal physician to Teddy Roosevelt and a president of the AMA beginning in 1910. According to Dr. Charles C. Smith, a physician who researched the activities of the committee and published a report in 1984: “He [Dr. Lambert] obviously was to be the needed ‘figurehead.’…The full time staff was headed by Harry H. Moore of Washington, who in 1927 published ‘American Medicine and the People’s Health’ while a member of Public Health Service. His main tenets were the need for a
system
[original emphasis] to distribute medical care and an insurance plan to pay for it.”

So early in the twentieth century, administrators and economists were deciding the future of America’s health care. Moore was aided by C. Rufus Rorem, who received a PhD in economics at the University of Chicago, which was founded and funded by Rockefeller. Rorem, according to Smith, was more concerned about hospital prepayment than in health care. Following his work for the CCMC, Rorem went on to become executive director of the Blue Cross Plan Commission between 1936 and 1946.

“I think the most important principle spawned by this Committee was not at all what was planned,” wrote Dr. Charles C. Smith Jr., who authored a medical history study paper on the committee. A minority on the committee fruitlessly recommended that government competition in the medical practice be discontinued. They also argued in opposition to corporate medicine being financed through intermediary agencies, such as health maintenance organizations (HMOs). Allegedly, these types of organizations exploit the medical professions and fail to provide high-quality health care.

“The tenor of the [CCMC] report was such that one can read into it the seeds of everything that led to the health care system we have today…. So at last we find ourselves, as always, in a health care crisis,” Dr. Smith wrote in 1984. This health-care crisis continues today.

“Rockefeller’s General Education Board has spent more than $100 million to gain control of the nation’s medical schools and turn our physicians to physicians of the allopathic school, dedicated to surgery and the heavy use of drugs,” wrote author Mullins, who spent more than thirty years researching the Rockefeller medical monopoly.

Recalling how John D. Rockefeller Sr.’s father, William “Big Bill” Rockefeller, once tried to sell unrefined petroleum as a cancer cure, Mullins wrote, “This carnival medicine show barker would hardly have envisioned that his descendents would control the greatest and most profitable Medical Monopoly in recorded history.”

Mullins reported that the German chemical company I. G. Farben and its subsidiaries in the United States through the Rockefeller interests (such as the cartel between Rockefeller’s U.S.-based Standard Oil Co. and I. G. Farben as revealed in a 1941 investigation by the government) were responsible for trying to build a monopoly by suppressing discoveries of its own drugs. From 1908 to 1936, I. G. Farben withheld its discovery of sulfanilamide, an early sulfa drug, until the firm had signed working agreements with the important drug firms of Switzerland, Sandoz and Ciba-Geigy. After years of a working relationship, these two firms were finally joined in 1996 to form one of the largest corporate mergers in history—Novartis.

During the first half of the twentieth century, the Nazi drug cartel, I. G. Farben, along with the drug companies controlled through Rockefeller interests, dominated the development, production, and distribution of numerous drugs, including substances that are downright dangerous.

ASPARTAME

A
MERICANS AREN’T JUST BEING
affected by chemicals in pharmaceutically produced drugs. One of the many controversial chemicals now being used by millions of Americans is aspartame, an additive sugar substitute found in most diet soft drinks and more than five thousand foods, drugs, medicines, and most sugar substitutes such as NutraSweet, Equal, Metamucil, and Canderel.

When heated to more than 86 degrees Fahrenheit, aspartame releases free methanol, which breaks down into formic acid and formaldehyde in the body. Keep in mind the human body temperature is 98.6 degrees and that formaldehyde is a deadly neurotoxin. The remaining formaldehyde from free methanol then breaks down into formic acid—the venom of ant stings.

In 1987, Dr. Louis J. Elsas, a professor of pediatrics and director of the Division of Medical Genetics at Emory University, testified before the U.S. Senate Committee on Labor and Human Resources about phenylalanine, one of the two amino acids in aspartame. He said, “In the developing fetus such a rise in maternal blood phenylalanine could be magnified four to six fold by the concentrative efforts of the placental and fetal blood brain barrier and this concentration kills such cells in tissue culture. The effect of such an increased fetal brain concentrations in vivo would probably be much more subtle and expressed as mental retardation, microcephaly, or potential certain birth defects.” When Dr. Elsas told the senators about phenylalanine in 1987, infant autism rates were 1 in 1,500. Today they are 1 in 150 and rising. It would appear that certain drugs are wrecking our newborn children.

Dr. Madelon Price, a professor of neurobiology at Washington University, said, “Aspartic acid (aspartate) has been known to be a neurotoxin for 30 years [now 40 years]. Rodents that have ingested too much aspartame as infants are stunted as adults, obese and have sexual and reproductive dysfunctions.”

Until the Reagan administration, the Food and Drug Administration had refused to approve the use of aspartame. The FDA’s own toxicologist, Dr. Adrian Gross, told Congress that aspartame can contribute to or even cause seizures, brain tumors, and brain cancer, and violated the Delaney clause, which forbids putting anything in food that is known to cause cancer. “And if the FDA violates its own laws, who is left to protect the public?” he asked.

Dr. H. J. Roberts with the Palm Beach Institute for Medical Research devoted an entire chapter of his book
Aspartame Disease: An Ignored Epidemic
to aspartame interaction with drugs such as Coumadin, Dilantin, antidepressants, and other psychotropic agents as well as Inderal, Aldomet, hormones, and insulin. Roberts said aspartame interacts with all cardiac medication, and even noted drug reactions after a person stopped using aspartame products. “The issue of sudden death related to aspartame and its breakdown products has been raised a number of times, particularly among previously well individuals using such products…including pilots and drivers, and athletes….” He added, “The need for clinicians and corporate-neutral investigators to evaluate the contributory role of aspartame in cardiopulmonary disorders and sudden death, and drug interactions with aspartame, is underscored by the frequency of persons dying unexpectedly being categorized as ‘death due to causes yet to be determined.’”

Dr. Betty Martini, a twenty-two-year veteran in the medical field and founder of Mission Possible International, has worked with doctors around the world to remove aspartame from food, drinks, and medicine. She recounted how pharmaceutical interests subordinated public welfare:

Yet even with friends in high places, the FDA still refused to allow NutraSweet on the market. Termed a deadly neurotoxic drug masquerading as an additive by opponents, aspartame interacts with antidepressants and also interacts with vaccines and other toxins and unsafe sweeteners like Splenda. “Both being excitotoxins, the aspartic acid in aspartame and MSG, the glutamate people were found using aspartame as the placebo for MSG studies, even before it was approved. The FDA has known this for a quarter of a century and done nothing even though it’s against the law. Searle went on to build a NutraSweet factory and had $9 million worth of inventory,” said Martini. Donald Rumsfeld was on President Reagan’s transition team and the day after Reagan took office, Dr. Arthur Hull Hayes, the man who would approve aspartame, was appointed as FDA commissioner.

Former Searle salesperson Patty Wood Allott supported the idea that Rumsfeld was behind the approval of aspartame by stating that in 1981 Rumsfeld told company employees “he would call in all his markers and that no matter what, he would see to it that aspartame be approved [that] year.” FDA commissioner Hayes had previously served in the U.S. Army Chemical Weapons Division and initially had approved aspartame only as a powdered additive. But in 1983, just before he left his position for a public relations job with Burson-Marsteller, the chief public relations firm for both Monsanto and Searle, Hayes approved aspartame for all carbonated beverages. Since that time he never spoke publicly about aspartame (Hayes died in February 2010).

Rumsfeld is merely one example of the cozy relationship between government and Big Pharm. A former CEO of Searle and a member of the Trilateral Commission—a globalist group designed to foster economic cooperation between the United States, Japan, and Europe—Rumsfeld is also a major stockholder in Gilead Sciences, a California biotech firm that owns the rights to Tamiflu. When the population was being threatened with the bird flu in 2005, CNN reported Rumsfeld’s Gilead holdings at somewhere between $5 million to $25 million.

The incestuous relationship between Big Pharm corporate business and the government makes a mockery of American free enterprise. While it is free to decide which drugs to promote and distribute, it is also free to price them as high as the traffic will bear. Yet Big Pharm is dependent on government in the form of patent protection and FDA approval to protect its drug monopoly.

In a move bewildering to those who are not aware of the globalist agenda and its control, Congress expressly prohibited Medicare from negotiating lower drug prices through its bulk purchasing power. The excesses of the globalists’ pharmaceutical corporations have prompted many Americans to seek price relief by traveling to Canada or Mexico to purchase drugs.

Dr. Angell said the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs and it now primarily a marketing machine to sell drugs of dubious benefit. Big Pharm “uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself [as] most of its marketing efforts are focused on influencing doctors, since they must write the prescriptions,” she said.

Don’t look for any real relief from either Democrats or Republicans. While campaigning in 2008 both then senators Barack Obama and Hillary Clinton pledged to fight the huge pharmaceutical and insurance industries. These promises echoed similar promises made by Mrs. Clinton during her husband’s administration. Yet campaign contributions data showed that both Obama and Clinton were the largest recipients of Big Pharm donations in 2008 campaign funding. According to the Center for Responsive Politics, Obama received $1,425,501 from the health service sector and health maintenance organizations (HMOs), while Clinton came in second with $575,746 in contributions. Trailing both Obama and Clinton were $427,228 for John McCain and $186,700 for Mitt Romney.